Characterization of the Heme and Pyridoxal Phosphate Cofactors of Human Cystathionine β-Synthase Reveals Nonequivalent Active Sites
- 5 February 1999
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 38 (9) , 2738-2744
- https://doi.org/10.1021/bi9826052
Abstract
Cystathionine β-synthase is an unusual enzyme that requires the cofactors heme and pyridoxal phosphate (PLP) to catalyze the condensation of homocysteine and serine to generate cystathionine. This transsulfuration reaction represents one of two major cellular routes for detoxification of homocysteine, which is a risk factor for atherosclerosis. While the β-replacement reaction catalyzed by this enzyme suggests a role for the pyridoxal phosphate, the role of the heme is uncertain. In this study we have examined the effect of changing one of the ligands to the heme on the activity of the enzyme. Binding of carbon monooxide results in the displacement of a thiolate ligand to the ferrous heme, and is accompanied by complete loss of cystathionine β-synthase activity. Furthermore, inhibition by CO is competitive with respect to homocysteine, providing the first indication that the homocysteine binding site is in the proximity of heme. Binding of both CO and cyanide to ferrous cystathionine β-synthase occurs in two distinct isotherms and indicates that the hemes are nonequivalent. We have employed fluorescence spectroscopy to characterize the bound PLP and its interaction with serine. PLP bound to cystathionine β-synthase is weakly fluorescent and exists as a mixture of the protonated and unprotonated tautomers. Reaction with hydroxylamine releases the oxime and greatly enhances the associated fluorescence. Binding of serine is accompanied by a shift to the unprotonated tautomer of the external aldimine as well as the appearance of a new fluorescent species at ∼400 nm that could be due to the aminoacrylate or to a gemdiamine intermediate. These data provide the first characterization of the PLP bound to cystathionine β-synthase. Treatment of cystathionine β-synthase with hydroxylamine releases two PLPs after 1 day and results in complete loss of activity. Incubation for an additional 3−4 days results in the release of two more PLPs. These data lead us to revise the PLP stoichiometry to 4 per tetramer, and to the conclusion that the heme and PLP sites in cystathionine β-synthase are nonequivalent.Keywords
This publication has 10 references indexed in Scilit:
- Redox-controlled Ligand Exchange of the Heme in the CO-sensing Transcriptional Activator CooAJournal of Biological Chemistry, 1998
- Evidence for Heme-mediated Redox Regulation of Human Cystathionine β-Synthase ActivityJournal of Biological Chemistry, 1998
- Human Betaine–Homocysteine Methyltransferase Is a Zinc MetalloenzymeArchives of Biochemistry and Biophysics, 1998
- Characterization of the Zinc Binding Site in Methionine Synthase Enzymes of Escherichia coli: The Role of Zinc in the Methylation of HomocysteineJournal of the American Chemical Society, 1998
- Correction of disease-causing CBS mutations in yeastNature Genetics, 1998
- Homocysteine and Cardiovascular DiseaseAnnual Review of Medicine, 1998
- Transsulfuration depends on heme in addition to pyridoxal 5'-phosphate. Cystathionine beta-synthase is a heme protein.Journal of Biological Chemistry, 1994
- Hemoprotein H-450 Identified as a Form of Cytochrome P-450 Having an Endogenous Ligand at the 6th Coordination Position of the HemeThe Journal of Biochemistry, 1984
- Extensive studies of the heme coordination structure of indoleamine 2,3-dioxygenase and of tryptophan binding with magnetic and natural circular dichroism and electron paramagnetic resonance spectroscopyBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984
- Methionine metabolism in mammals. Distribution of homocysteine between competing pathways.Journal of Biological Chemistry, 1984